$0.98
+0.05 (+5.28%)
Open$0.97
Previous Close$0.93
Day High$1.02
Day Low$0.97
52W High$3.28
52W Low$1.18
Volume—
Avg Volume755.5K
Market Cap595.58M
P/E Ratio—
EPS$-0.82
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
+2,294.5% upside
Current
$0.98
$0.98
Target
$23.50
$23.50
$17.63
$23.50 avg
$33.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 579.50M | 650.68M | 156.52M |
| Net Income | -535,318,932 | -540,969,053 | 22.40M |
| Profit Margin | -92.4% | -87.8% | 14.3% |
| EBITDA | -318,484,724 | -339,726,575 | 28.04M |
| Free Cash Flow | — | — | 15.05M |
| Rev Growth | -10.9% | -10.9% | +1.7% |
| Debt/Equity | 0.35 | 0.35 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |